Track topics on Twitter Track topics that are important to you
Founded about a year ago, Lichtinger says the company's transdermal patch technology will help cancer patients going through chemotherapy to experience significantly less side effects of the drug including less nausea and vomiting.
Lichtinger says the company is planning to go public and list on the Nasdaq and the TSX in about 10 months, using the capital raised to run the clinical trials for the drug.NEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...